Page last updated: 2024-10-26

dipyridamole and Polyuria

dipyridamole has been researched along with Polyuria in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Polyuria: Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Díaz de León Ponce, M1
López-Llera, M1
Rubio Linares, G1

Other Studies

1 other study available for dipyridamole and Polyuria

ArticleYear
[Acute renal insufficiency with high urine output in preeclampsia and in eclampsia].
    Ginecologia y obstetricia de Mexico, 1975, Volume: 37, Issue:224

    Topics: Acute Kidney Injury; Dipyridamole; Disseminated Intravascular Coagulation; Eclampsia; Female; Humans

1975